Presentation is loading. Please wait.

Presentation is loading. Please wait.

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Published byAugustus Francis Modified over 6 years ago

Similar presentations

Presentation on theme: "Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:"— Presentation transcript:

1 Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator: A pilot study  Stanislava Zabarovskaja, MD, Fredrik Gadler, MD, PhD, Anders Gabrielsen, MD, PhD, Cecilia Linde, MD, PhD, Lars H. Lund, MD, PhD  The Journal of Heart and Lung Transplantation  Volume 32, Issue 6, Pages (June 2013) DOI: /j.healun Copyright © 2013 International Society for Heart and Lung Transplantation Terms and Conditions

2 Figure 1 Flow chart shows cardiac resynchronization therapy (CRT) or implantable cardioverter-defibrillator (ICD) patients screened for heart transplantation (HTx) and left ventricular assist device (LVAD). BTT, bridge-to-transplant; COPD, chronic obstructive pulmonary disease; DT, destination therapy; HF, heart failure; NYHA, New York Heart Association. *These 30 patients had ICD for other indications. #Patients with contraindication. Listed contraindications are not mutually exclusive. The Journal of Heart and Lung Transplantation  , DOI: ( /j.healun ) Copyright © 2013 International Society for Heart and Lung Transplantation Terms and Conditions

Download ppt "Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:"

Similar presentations

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.
Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,
Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Date of download: 6/26/2016 From: Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter- Defibrillator Versus.

Date of download: 6/26/2016 From: Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter- Defibrillator Versus.
Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I

Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I
Intramyocardial bone marrow mononuclear cell transplantation in ischemic heart failure: Long-term follow-up  Miia Lehtinen, MD, Tommi Pätilä, MD, PhD,

Intramyocardial bone marrow mononuclear cell transplantation in ischemic heart failure: Long-term follow-up  Miia Lehtinen, MD, Tommi Pätilä, MD, PhD,
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure  Clyde W. Yancy, MD, MSc, MACC, FAHA, FHFSA, Mariell.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure  Clyde W. Yancy, MD, MSc, MACC, FAHA, FHFSA, Mariell.
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice  Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice  Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,
Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management  E.A. Hamad, V. Devlin, K. McDonnell, N. Robinson, M. Welsh, E. Kerr,

Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management  E.A. Hamad, V. Devlin, K. McDonnell, N. Robinson, M. Welsh, E. Kerr,
Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:

Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 
Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention 

Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention 
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,

Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation  Ratika Parkash, MD, MSc, François Philippon,

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation  Ratika Parkash, MD, MSc, François Philippon,
Myocarditis in Clinical Practice

Myocarditis in Clinical Practice

Similar presentations

Ads by Google